Ilsung Pharmaceuticals and Huons made the exclusive sale contract for the arteriosclerosis drug ‘Arigrel’
Ilsung Pharmaceuticals (CEO Suk-geun Yoon) and Huons (CEO Jae-gab Jeon) held a signing ceremony of their exclusive sale contract for the arteriosclerosis treatment ‘Arigrel’ on the last 1st.
Under the contract, Arigrel Cap, which is manufactured by Huons, will be supplied through the Ilsung Phar...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
